Nuray chemicals

Thiruvarur, India Founded: 2012 • Age: 14 yrs
Manufactures active pharmaceutical ingredients for global generic players.

About Nuray chemicals

Nuray chemicals is a Healthcare company based in Thiruvarur (India) founded in 2012 by Muthusamy Shanmugam. It manufactures active pharmaceutical ingredients for global generic players. It operates on a B2B model. The company has 336 employees. Its chief executive, as recorded, is Muthusamy Shanmugam. Its Indian entity Nuray Chemicals Private Limited reported revenue of β‚Ή122 Cr. Nuray chemicals offers products and services including Atropine Sulfate Monohydrate, Dapsone, Chlorzoxazone, L-Methyl Folate, and Piribedil. Its focus areas include R&D Services, Drug Development, NCE Synthesis and Pharmaceuticals. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.

Company details

Nuray Chemicals , Established In 2012, Specializes In Developing And Manufacturing Active Pharmaceutical Ingredients (apis) Through Chemical Synthesis And Rd. Based In Tamilnadu, India, With A Presence In The Usa, It Focuses On Quality Compliance And Serves Global Generic Pharmaceutical Companies By Delivering A Diverse Product Portfolio And Innovative Capabilities.

  • Headquarters Thiruvarur, India
  • Employees 336
  • Founders Muthusamy Shanmugam
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website nuraychemicals.com
  • Social LinkedIn
  • Legal Name Nuray Chemicals Private Limited
  • Date of Incorporation 14 Jun, 2012
  • Jurisdiction Thiruvallur, Tamil Nadu, India
Key Metrics
  • Annual Revenue
    ₹122 Cr

    FY 2025 · +16% YoY

  • Net Profit
    ₹7.32 Cr

    FY 2025 · 6% margin

  • EBITDA
    ₹17.20 Cr

    FY 2025 · 14% margin

  • Employee Count
    336

Products & Services of Nuray chemicals

Nuray chemicals offers a comprehensive portfolio of products and services, including Atropine Sulfate Monohydrate, Dapsone, Chlorzoxazone, L-Methyl Folate, and Piribedil.

Atropine Sulfate Monohydrate
API

Active ingredient used in pharmaceuticals for medical applications.

Dapsone
API

Antibiotic compound for treating bacterial infections.

Chlorzoxazone
API

Muscle relaxant for pain relief purposes.

L-Methyl Folate
API

Nutritional supplement for folate deficiency.

Piribedil
API

Medication for neurological disorders.

Trientine Hydrochloride
API

Treatment for copper accumulation diseases.

Board of directors of Nuray Chemicals Private Limited (Nuray chemicals)

Nuray Chemicals Private Limited is the primary company behind Nuray chemicals. The board of Nuray Chemicals Private Limited currently have 4 directors; the longest-serving is Ayyavu Rajavel, appointed in 2012. 4 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ayyavu Rajavel
DIN 02751833
Alternate Director14 Jun 201214 yrs 5 moNuray Chemicals Private Limited
Jaganathan Jayaseelan
DIN 01688806
Director14 Jun 201214 yrs 5 moNuray Chemicals Private Limited
Shanmugam Muthusamy
DIN 02684873
Director20 Jul 201610 yrs 3 moNuray Chemicals Private Limited
Ravi Kulandasamy
DIN 08719284
Director04 Mar 20206 yrs 8 moNuray Chemicals Private Limited

People of Nuray chemicals

22 people are tracked at Nuray chemicals (6 in leadership, 16 in team); the tracked headcount is 336.

NameRoleGroup
Founder, CEOLeadership
Ayyemperumal Kulandaivel
CEOLeadership
Prasanna Venkatesan
Head Of ComplianceLeadership
Rameshkumar Mariappan
General Manager Quality ControlLeadership
DirectorLeadership
Dr. G. Panchapakeaan Ganapathy
Head Of Research And DevelopmentLeadership
Venkatesh Santhanam
Senior Scientist - Analytical DevelopmentTeam
Abdul Raheem
Junior ExecutiveTeam
Gokula Krishnan
Quality Assurance TraineeTeam
Senthil Kaliyamoorthy
Senior Scientist In API Pharma(r&d)Team
Muthu Samy
ExecutiveTeam
Dr. Ganesh Sarathy
Senior Group LeaderTeam
Madhu Eswaran
Quality Control ChemistTeam
Muthu Sakthivel
Junior ExecutiveTeam
Karthik P
ScientistTeam
Saravanan Baluswamy
Deputy ManagerTeam
Gunasekar Sivakotti
Senior ManagerTeam
Kesavan Mani
Senior Executive PurchaseTeam
M.D. Yaseen
Assistant Manager Quality Assurance At Nuray Chemicals Pvt. Ltd.Team
Gokulprasath Sekar
Human Resources ExecutiveTeam

2 more people are available in the full profile.

Premium access

Complete people profiles for Nuray chemicals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Nuray chemicals

Figures of Nuray Chemicals Private Limited, the primary company behind Nuray chemicals, for FY 2025. Revenue was ₹122 Cr (+16% year on year). Net profit was ₹7.32 Cr (6% margin). EBITDA was ₹17.20 Cr (14% margin). Revenue has grown at a compounded annual rate of +15% over three years and +21% over five years.

  • ₹122 CrRevenue · FY 2025 · +16% YoY
  • ₹7.32 CrNet profit · 6% margin
  • ₹17.20 CrEBITDA · 14% margin
  • ₹23.84 CrPaid-up capital
  • 336Employees (provident fund records)
  • +15%Revenue CAGR, 3 years
  • +21%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Nuray Chemicals Private Limited are on its company page.

Premium access

Detailed financial statements for Nuray chemicals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Nuray chemicals

Nuray chemicals has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed similar companies of Nuray chemicals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Nuray Chemicals

Premium access

Complete news archive for Nuray chemicals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nuray chemicals

Nuray chemicals was founded in 2012.

Nuray chemicals is headquartered in Thiruvarur, India. It is registered at Thiruvarur, Tamil Nadu, India.

Muthusamy Shanmugam is the CEO of Nuray chemicals, as recorded in our data. They have also founded this company.

Nuray chemicals has 336 employees.

The primary company behind Nuray chemicals, Nuray Chemicals Private Limited, reported revenue of β‚Ή122 Cr for FY 2025, up 16% year on year.

Nuray Chemicals , Established In 2012, Specializes In Developing And Manufacturing Active Pharmaceutical Ingredients (apis) Through Chemical Synthesis And Rd. Based In Tamilnadu, India, With A Presence In The Usa, It Focuses On Quality Compliance And Serves Global Generic Pharmaceutical Companies By Delivering A Diverse Product Portfolio And Innovative Capabilities.

Nuray chemicals's top competitors include Laurus Labs, Symbiotec and SeQuent.

Nuray chemicals offers Atropine Sulfate Monohydrate, Dapsone, Chlorzoxazone, L-Methyl Folate, and 2 more products and services.

Nuray chemicals operates through Nuray Chemicals Private Limited.

The legal entities of Nuray chemicals currently have 4 directors, including Ayyavu Rajavel, Shanmugam Muthusamy, Jaganathan Jayaseelan and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available